InvestorsHub Logo
Followers 200
Posts 10576
Boards Moderated 0
Alias Born 11/29/2011

Re: FullDeck post# 79302

Thursday, 01/29/2015 11:43:44 AM

Thursday, January 29, 2015 11:43:44 AM

Post# of 92701
Wrong. #BudGenius Testing Lab is Just the Tip of the Spear...

http://www.otcmarkets.com/stock/righ/profile

BG Medical is a technology and services provider for the medical cannabis industry. The company delivers an educational consumer experience through an expanding suite of software and services. BG Medical's flagship brand, BudGenius.com, is an online portal providing medicine matching and directory services enabling patients to select and locate the most effective cannabis for their ailments. BG Laboratories provides potency, pesticide, and contaminant analysis reporting for medical cannabis.


Angel explains the lab's importance here.

Angel Stanz (BG Medical)
To
me
Oct 8
BN,

Lab testing creates consumer relationships and business relationships (dispensaries, farmers, manufacturers). This forms a brand that emanates as a beacon of trust in buying power for both sides of the retail equation. The result is data collection and business intelligence analytics that pave the path for additional business models that are aligned with profits stemming from purchasing dollars (transactions), suggest selling to consumers (targeted advertising), and retail business optimization. Testing represents an expense line on the balance sheet of our retail customers. For this reason, a lab will always work against downward pricing pressure (further increased by competitors). The latter models represents a relationship with top line earnings, a more desirable proposition, because it represents greater increased income for retail customers.

The former enables the latter. This is a summary look at our vertical integration strategy.

Warm Regards,

Angel Stanz, CEO
BG Medical Technologies, Inc.
RightSmile, Inc.
*******@bgmedtech.com
(855) ***-****


BudGenius' $$$ money is lining up via technology and software.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=107989949

excerpts from the Q2/2014 Financials below in red...

Upon facilitation of capital financing agreements erected in Q4 2013, new products and services for consumers and businesses are expected to resume development for enhancing the BudGenius software and data collection platform, including but not limited to, mobile app development, online transparency for laboratory workflow, marijuana genetics and strain mapping, marijuana heritage profiles to highlight sustained and exceptional farmer pedigree, business intelligence data gathering tools, consumer purchase pattern analysis, medical efficacy analysis, loyalty programs, portable diagnostic hardware for patients, and internal tools to optimize company workflow for the purpose of reducing cost of goods sold."

http://otcmarkets.com/otciq/ajax/showFinancialReportById.pdf?id=125532